2005 News Releases

• News Release - December 6, 2005
  New guiding principle further strengthen and improve Rx&D Code of Conduct. Read more

• News Release - November 16, 2005
  Rx&D Launches Industry Code of Conduct Education Program. Read more

• News Release - November 15, 2005
  New Chairman of the Board of Rx&D. Read more

• Letter-to-the-Editor - November 8, 2005
  The Winnipeg Free Press published a Letter-to-the-Editor from Russell Williams, President of Rx&D in which he talks about the Code of Conduct and the ethical business relationship the pharmaceutical community has with health care professionals. Read more

• Speech - November 1, 2005
  Rx&D President Russell Williams was a guest speaker at the Canadian Manufacturers and Exporters' Annual Conference and Trade Show in Toronto. Mr. Williams spoke about the importance of data protection for Canada. Read more

• Letter-to-the-Editor - October 21, 2005
  The Globe and Mail, The National Post, The Ottawa Citizen and The Edmonton Journal published a letter-to-the-Editor from Russell Williams, President of Rx&D in response to articles on a survey by Nature magazine. Read more

• Op-Ed - October 20, 2005
  The Vancouver Sun published an opinion editorial from Russell Williams, President of Rx&D on the value of new medicines. Read more

• News Release - October 14, 2005
  CDR report: patients fail to gain timely access to new medicines. Read more

• News Release - October 4, 2005
  Rx&D asks for immediate first step to attract R&D investments in Canada. Read more

• Speech - October 4, 2005
  Presentation to the House of Commons Standing Committee on Finance Pre-Budget Consultations. Read more

• Report - October 4, 2005
  Rx&D Companies: Driving a Better, Stronger Canadian Economy. Read more

• News Release - September 21 , 2005
  Launch of First Worldwide Clinical Trials Portal: more transparency for patients and healthcare professionals. Read more
  
  This link to the IFPMA Clinical Trials Portal ("CTP") is provided by Rx&D for informational purposes only. While Rx&D member companies will endeavor to ensure that information available on their respective Canadian clinical trials available through the CTP is complete and accurate, Rx&D assumes no responsibility or liability for the CTP, or for any Internet sites that visitors may access through the CTP, and makes no representations, warranties, guarantees, or commitments of any kind with respect to the linked sites and/or their respective contents.To access the clinical trials portal, click here.

• Speech - August 24, 2005
  Quebec's Draft Pharmaceutical Policy: Presentation by André Marcheterre, CEO of Merck and Jean-Michel Halfon, CEO of Pfizer Canada on behalf of Rx&D to Quebec's Social Affairs Commission. Read more



• News Release - August 24, 2005
  The Charest government must maintain pharmaceutical innovation in Quebec. Read more

 
• Quebec's Draft Pharmaceutical Policy - August 24, 2005
  Please read the Brief by Rx&D tabled to Quebec's social affairs commission. Read More
   
• Article - July 11, 2005
  Geoff Mitchinson, Vice-President at GlaxoSmithKline, says Canada's Innovation is at crossroads in the latest edition of CME Magazine. Read More



• Information Card - June 21, 2005
  The Innovative Pharmaceutical Industry - Facts You Should Know Read More

• News Release - June 15, 2005
  PMPRB Report: Global Competitiveness Critical to Increased R&D. Read More

• Speech - June 2, 2005
  Micheal Cloutier, CEO of AstraZeneca, gave a speech on the importance of Innovation before the Board of Trade of Metropolitan Montreal. Read More

• News Release - May 27, 2005
  Rx&D responds to Health Canada's ADR Online Database announcement. Read More

• News Release - May 12, 2005
  Ontario Budget: Rx&D welcomes health commitments. Read More

• Article - May 2, 2005
  Columbia University Professor Frank Lichtenberg discusses the overall positive impact of new medicines on patients and the economy: "Living better, longer." Read More

• News Release - April 28, 2005
  Rx&D commends health care, R&D, and competitiveness measures in Nova Scotia budget. Read More

• Letter-to-the-Editor - April 18, 2005
  The Hill Times - Canada at crossroads as a world leader in pharmaceutical and biopharmaceutical innovation says Rx&D president Russell Williams. Read More

• News Release - April 7, 2005
  Following a report published by CIHI, Rx&D's president says that new medicines play a key role in Canadians' overall healthcare. Read More

• News Release - March 29, 2005
  Rx&D says the new Smart Regulation launched by the federal government is a first step in the right direction to improve innovation in Canada. Read More

• Letter-to-the-Editor - March 21, 2005
  The Globe and Mail - Rx&D President Russell Williams writes about the negative effects of restrictive policies such as reference-based pricing (RBP) on the Canadian health care system. Read More

• Article - March 1, 2005
  Gilles Gagnon, President and CEO of AEternaZentaris and a member of Rx&D's Board, wrote an article in Montreal Business Magazine: "Fostering R&D Partnerships in Canada." Read More

• News Release - February 23, 2005
  Federal Budget: Rx&D invites government to seize opportunity. Read More

• Speech - February 15, 2005
  André Marcheterre, chairman of Rx&D - "Innovation brings better healthcare to Canadians". Read More

• News Release - January 6, 2005
  Rx&D Supports the Creation of an International Registry of Clinical Trials. Read More